Biotech Values

[iwfal]

Ifn-lambda

Any idea why they canceled this study?




clinicaltrials.gov/ct2/show/NCT01447394

Probably because they will already have the data from the previous large randomized ph ii (interim results here #msg-61755220) - but they want to pursue a different path to approval than as a single agent in a traditional treatment regimen (e.g. perhaps they want to get it approved as part of a BMY regimen).